Investigation of the role of interleukin-1 family members, IL-33 and IL-36, in the pathogenesis of colon cancer

Show simple item record

dc.contributor.advisor Aileen Houston en
dc.contributor.advisor Brint, Elizabeth K. en
dc.contributor.author O'Donnell, Charlotte
dc.date.accessioned 2017-03-21T10:31:02Z
dc.date.issued 2016
dc.date.submitted 2016
dc.identifier.citation O'Donnell, C. 2016. Investigation of the role of interleukin-1 family members, IL-33 and IL-36, in the pathogenesis of colon cancer. PhD Thesis, University College Cork. en
dc.identifier.endpage 218 en
dc.identifier.uri http://hdl.handle.net/10468/3793
dc.description.abstract The importance of inflammation in cancer is well established, with cytokines/chemokines playing an important role in carcinogenesis. IL-33 was recently identified as the ligand for ST2. ST2 is a member of the toll-like receptor/IL-1 receptor family. Three isoforms of ST2 exist: a trans-membrane receptor (ST2L), a secreted soluble form (sST2), and a variant form (ST2V). The IL-33/ST2 pathway has been implicated in inflammatory bowel disease, a major risk factor for colon cancer. The aim of the first part of my thesis was to investigate the role of IL-33 and ST2 in colon cancer. CT26 and HT29 colon cancer cells were found to express ST2 and IL-33 in vitro, with expression increased by inflammatory mediators (LPS, TNF-α and PGE2). Stimulation with IL-33 increased the migration, but not proliferation, of colon tumour cells. Functional analyses showed that stimulation with IL-33 induced the expression of CXCL-1 by CT26 and CCL2 expression by HT29 cells. To investigate the role of ST2 in vivo, ST2 knockdown cells were generated using ST2-specific shRNA (CT26 ST2shRNA) and injected subcutaneously into BALB/C mice. Knockdown of ST2 in colon tumours resulted in enhanced tumour growth (2.3 fold increase compared to CT26 scrshRNA) in vivo. This was associated with alterations in immune cell infiltration, including an increase in macrophage infiltration. In contrast, characterisation of human colon tumours revealed that ST2L expression was increased in tumour cells relative to adjacent non-tumour cells, with no change in expression of total ST2. These results indicate that the IL-33/ST2 signalling axis may play an important role in colon carcinogenesis and merits further investigation. The role of the IL-36R, a second IL-1R family member, in colon cancer was investigated in the second part of my thesis. Characterization of human colon tumours ex vivo showed significantly increased expression of the IL-36 ligands, IL-36α and IL-36γ, compared to adjacent non-tumour tissue. In vitro colon cancer cell lines HT29 and SW480 were shown to express the IL-36R and IL-36 ligands. IL-36α and IL-36γ stimulation of HT29 cells also increased the expression of the chemokines CXCL-1, CCL2, CCL20, and IL-8. This suggests that IL-36 signalling may promote tumour-derived immune cell recruitment. This field requires further study to determine if the recruitment of immune cells by IL-36 signalling could be utilised to break tolerance against tumour antigens. This thesis has laid the basis for further studies to explore the role of IL-36 signalling in colon cancer. en
dc.description.sponsorship Health Research Board (PhD/2007/4) en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher University College Cork en
dc.rights © 2016, Charlotte O'Donnell. en
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/ en
dc.subject Colon cancer en
dc.subject IL-33 en
dc.subject ST2 en
dc.subject IL-36 en
dc.title Investigation of the role of interleukin-1 family members, IL-33 and IL-36, in the pathogenesis of colon cancer en
dc.type Doctoral thesis en
dc.type.qualificationlevel Doctoral Degree (Structured) en
dc.type.qualificationname PhD Scholars Programme in Cancer Biology en
dc.internal.availability Full text available en
dc.description.version Accepted Version
dc.contributor.funder Health Research Board en
dc.description.status Not peer reviewed en
dc.internal.school Biosciences Institute en
dc.internal.school Medicine en
dc.check.reason This thesis is due for publication or the author is actively seeking to publish this material en
dc.check.opt-out Not applicable en
dc.thesis.opt-out false
dc.check.entireThesis Entire Thesis Restricted
dc.check.embargoformat E-thesis on CORA only en
ucc.workflow.supervisor a.houston@ucc.ie
dc.internal.conferring Spring 2017 en


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2016, Charlotte O'Donnell. Except where otherwise noted, this item's license is described as © 2016, Charlotte O'Donnell.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement